6
Oct
2026
Axplora Group GmbH
Exhibitor at CPHI Milan 2026 stand 3C1, API
About Us
Categories
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 3C1, API
Products Featured at CPHI Milan 2026
-
Product Ursodeoxycholic Acid
Axplora manufactures a wide range of commercial APIs which includes Ursodeoxycholic Acid, Ursodiol, UDCA.
Therapeutic area: Cholelitholytic agent.
Monograph: PH.EUR.,IP,JP
Grades: Standard, milled, milled HF, micronized.
Regulatory Document... -
Product Omega 3 Eicosapentanoic Acid Ethyl Esther
Axplora manufactures a wide range of commercial APIs which includes Omega 3 Eicosapentanoic Acid Ethyl Esther, Icosapent Ethyl.
Therapeutic area: Anti-Inflammatory, Cardiovascular.
Monograph: API QUALITY.
Grades: Standard.
Regulatory Documen... -
Product Mesalamine
Axplora manufactures a wide range of commercial APIs which includes Mesalamine, Mesalazine, 5-Aminosalicylic, Acid, ASA.
Therapeutic area: Anti-Inflammatory, Gastrointestinal.
Monograph: PH.EUR., USP, JP.
Grades: Dense, Fine, Fine Extra, Coarse.&... -
Product Beclomethasone Dipropionate
Axplora manufactures a wide range of commercial APIs which includes Beclomethasone Dipropionate.
Therapeutic area: Respiratory.
Grades: Anhydrous crystalline, Anhydrous micronized, Anhydrous sterile micronized, Monohydrate micronized.
Regulatory Documentation: CEP, EU DMF, US DMF...
Axplora Resources (1)
-
Brochure API Product Portfolio
Axplora offers a comprehensive portfolio of small molecule APIs. We are a global leader in manufacturing non-sterile and sterile steroids as well as a leading supplier of specialty API products, including 5-ASA, UDCA, High Potent Substances (HPS) and anticancer drugs.




